Biotronik SE & Co. KG
123
12
22
82
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
8.9%
11 terminated/withdrawn out of 123 trials
88.2%
+1.6% vs industry average
15%
18 trials in Phase 3/4
20%
16 of 82 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (123)
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
Role: collaborator
BIO|STREAM.CSP CLS
Role: lead
BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs
Role: lead
Full Early Atrial Diagnostics in Single Chamber ICD Patients Using the DX Lead and Home Monitoring in Brazil.
Role: lead
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Role: collaborator
BIO|STREAM.CSP Study
Role: lead
Pacing Characteristics of a Conventional Bipolar
Role: collaborator
Home Monitor for AA Burden Detection IIT in TWN
Role: collaborator
To Evaluate the Delivery Timing Safety and Efficacy of AntiTachycardia Pacing (BIO|ATP)
Role: lead
Conduction System Pacing International Registry (CONSPIRE)
Role: collaborator
Loop Recorder Implantation in Patients With Mitral Annular Disjunction
Role: collaborator
MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study
Role: collaborator
BIO|CONCEPT.CorSky, First in Human Study for the CorSky ICD Family
Role: collaborator
Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices
Role: lead
BIOSTREAM.HF HeartInsight
Role: lead
One Day Implantation Program for Heart Failure Patients Implanted With CRT-P
Role: lead
BIO|MASTER.CSP Study
Role: lead
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Role: lead
Ticagrelor De-escalation Strategy in AMI Patients
Role: collaborator
Evaluation of the BIOTRONIK AutoAdapt Algorithm for Continuous Automatic Adaptive Cardiac Resynchronization
Role: lead